Slides
Recent presentations of the NDB in PowerPoint or Adobe PDF format.
Low Rates of Visual Loss in Hydroxychloroquine Treated Patients: Evidence to Revise Monitoring Guidelines - ACR 2003 (V. W. Cartwright, K. Michaud, H. K. Choi, F. Wolfe)
Lymphoma in Rheumatoid Arthritis: the Effect of Methotrexate and Anti–TNF Therapy in 18,572 Patients - ACR 2003 (Fred Wolfe, Kaleb Michaud)
Productivity Costs and Income Losses in Persons with Rheumatoid Arthritis - ACR 2003 (Fred Wolfe, Kaleb Michaud, Hyon K. Choi and Rhys Williams)
Tuberculosis Infection in Patients with Rheumatoid Arthritis and the Effect of Infliximab Therapy - ACR 2003 (Frederick Wolfe, Kaleb Michaud, Janice Anderson, Kathy Urbanksy)
Methotrexate, Laboratory Testing and Risk of Serious Illness: Analyses in 20,000 Patients (V. W. Cartwright, K. Michaud, H. K. Choi, F. Wolfe)
Heart Failure in Rheumatoid Arthritis: Rates, Predictors and the Effect of Anti-TNF Therapy (Fred Wolfe & Kaleb Michaud)
The DAS Score is Not Suitable as the Sole Criterion for TNF Initiation and Evaluation in the Clinic: Evidence of Disagreement between Physician Assessments and DAS Scores, and limitations in the use of Questionnaires for Regulatory Purposes (F Wolfe, K Michaud, T Pincus, D Furst and E Keystone Wichita, Nashville, Los Angeles, Toronto and 61 RAES Investigators)
Treatment for Rheumatoid Arthritis and the Risk of Pneumonia (Fred Wolfe, Kaleb Michaud and Liron Caplan)
The Chord program and NDB Activities. Presented to 2002 and 2003 CHORD fellows and NDB rheumatologists collaborators (Orlando ACR meeting 2003)
